Publication: Bisphosphonate treatment as a cause of jaw osteonecrosis
dc.contributor.author | Özet, Ahmet | |
dc.contributor.author | Ataergin, Selmin A. | |
dc.contributor.author | Kuzhan, Okan | |
dc.contributor.author | Arpacı, Fikret | |
dc.contributor.author | Öztürk, Bekir | |
dc.contributor.author | Kömürcü, Şeref | |
dc.contributor.author | Öztürk, Mustafa | |
dc.contributor.buuauthor | Kanat, O. | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Tıbbi Onkoloji Ana Bilim Dalı | |
dc.contributor.scopusid | 6602187347 | |
dc.date.accessioned | 2024-03-08T12:44:31Z | |
dc.date.available | 2024-03-08T12:44:31Z | |
dc.date.issued | 2007-05 | |
dc.identifier.citation | Kanat, O. vd. (2007). "Bisphosphonate treatment as a cause of jaw osteonecrosis". Oral Diseases, 13(3), 346-347. | |
dc.identifier.doi | https://doi.org/10.1111/j.1601-0825.2007.01320.x | |
dc.identifier.eissn | 1601-0825 | |
dc.identifier.endpage | 347 | |
dc.identifier.issn | 1354-523X | |
dc.identifier.issue | 3 | |
dc.identifier.pubmed | 17448221 | |
dc.identifier.scopus | 2-s2.0-34247353789 | |
dc.identifier.startpage | 346 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1601-0825.2007.01320.x | |
dc.identifier.uri | https://hdl.handle.net/11452/40314 | |
dc.identifier.volume | 13 | |
dc.identifier.wos | 000245814400017 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.collaboration | Sanayi | |
dc.relation.journal | Oral Diseases | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Dentistry, oral surgery & medicine | |
dc.subject.emtree | Amoxicillin | |
dc.subject.emtree | Amoxicillin plus clavulanic acid | |
dc.subject.emtree | Ampicillin plus clavulanic acid | |
dc.subject.emtree | Antibiotic agent | |
dc.subject.emtree | Bisphosphonic acid derivative | |
dc.subject.emtree | Chlorhexidine | |
dc.subject.emtree | Metronidazole | |
dc.subject.emtree | Pamidronic acid | |
dc.subject.emtree | Unclassified drug | |
dc.subject.emtree | Zoledronic acid | |
dc.subject.emtree | Actinomyces | |
dc.subject.emtree | Antiangiogenic activity | |
dc.subject.emtree | Bone infection | |
dc.subject.emtree | Bone metastasis | |
dc.subject.emtree | Bone necrosis | |
dc.subject.emtree | Bone pain | |
dc.subject.emtree | Breast cancer | |
dc.subject.emtree | Cancer chemotherapy | |
dc.subject.emtree | Debridement | |
dc.subject.emtree | Drug substitution | |
dc.subject.emtree | Drug withdrawal | |
dc.subject.emtree | Human | |
dc.subject.emtree | Hyperbaric oxygen | |
dc.subject.emtree | Inflammation | |
dc.subject.emtree | Jaw | |
dc.subject.emtree | Letter | |
dc.subject.emtree | Mandible | |
dc.subject.emtree | Maxilla | |
dc.subject.emtree | Mouth flora | |
dc.subject.emtree | Multiple myeloma | |
dc.subject.emtree | Nonhuman | |
dc.subject.emtree | Pain | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Tooth extraction | |
dc.subject.emtree | Treatment duration | |
dc.subject.emtree | Vascularization | |
dc.subject.mesh | Anti-bacterial agents | |
dc.subject.mesh | Bone density conservation agents | |
dc.subject.mesh | Diphosphonates | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Imidazoles | |
dc.subject.mesh | Jaw diseases | |
dc.subject.mesh | Osteonecrosis | |
dc.subject.mesh | Tooth extraction | |
dc.subject.scopus | Jaw Osteonecrosis; Kienboeck Disease; Bisphosphonic Acid Derivative | |
dc.subject.wos | Dentistry, oral surgery & medicine | |
dc.title | Bisphosphonate treatment as a cause of jaw osteonecrosis | |
dc.type | Letter | |
dc.wos.quartile | Q2 (Dentistry, oral surgery & medicine) | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Tıbbi Onkoloji Ana Bilim Dalı | |
local.indexed.at | WOS | |
local.indexed.at | Scopus |